PTK2 and ductal breast carcinoma in situ: Although FAK inhibition in the absence of EVs did not affect invasion, the FAK inhibitor significantly abrogated the increase in EV-stimulated DCIS.com cell invasion to levels matching the untreated control (Fig. 5b, c).